MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,350 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 523,382 | $1,518,000 | 0.16% |
| Birchview Capital, LP | 77,570 | $231,000 | 0.15% |
| CSS LLC/IL | 78,207 | $233,000 | 0.02% |
| Perceptive Advisors | 179,419 | $534,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 683,356 | $1,982,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 15,961 | $46,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,738 | $5,000 | 0.00% |
| Renaissance Technologies | 166,123 | $495,000 | 0.00% |
| UBS Group AG | 1,124 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 12,104 | $36,000 | 0.00% |